Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures. The epileptic seizures show recurring episodes and occur due to wrong signal sent by nerve cells to the brain. Antiepileptic drugs also act as mood stabilizers and also used in the treatment of bipolar disorders or neuropathic pain.
The report details the trend, potential and market size of Anti Epilepsy Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti Epilepsy Drugsmarket, defines the market attractiveness level of Anti Epilepsy Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti Epilepsy Drugs industry, describes the types of Anti Epilepsy Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti Epilepsy Drugs market and the development prospects and opportunities of Anti Epilepsy Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti Epilepsy Drugs market in Chapter 13.
By Player:
UCB Pharma
Cephalon
GlaxoSmithKline
Sanofi
Novartis
Sunovion Pharmaceuticals
Pfizer
Abbott Laboratories
Johnson & Johnson
Valeant Pharmaceuticals
By Type:
First Generation AEDs
Second Generation AEDs
By End-User:
Partial
Generalized
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti Epilepsy Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti Epilepsy Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti Epilepsy Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti Epilepsy Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti Epilepsy Drugs Market Analysis and Outlook to 2022
-
7.1 Global Anti Epilepsy Drugs Consumption (2017-2022)
-
7.2 United States Anti Epilepsy Drugs Consumption (2017-2022)
-
7.3 Europe Anti Epilepsy Drugs Consumption (2017-2022)
-
7.4 China Anti Epilepsy Drugs Consumption (2017-2022)
-
7.5 Japan Anti Epilepsy Drugs Consumption (2017-2022)
-
7.6 India Anti Epilepsy Drugs Consumption (2017-2022)
-
7.7 South Korea Anti Epilepsy Drugs Consumption (2017-2022)
8 Region and Country-wise Anti Epilepsy Drugs Market Analysis and Outlook to 2028
-
8.1 Global Anti Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.2 United States Anti Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Anti Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.4 China Anti Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Anti Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.6 India Anti Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Anti Epilepsy Drugs Consumption Forecast (2022-2028)
9 Global Anti Epilepsy Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Anti Epilepsy Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global First Generation AEDs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Second Generation AEDs Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti Epilepsy Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Partial Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Generalized Consumption and Growth Rate (2017-2022)
10 Global Anti Epilepsy Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Anti Epilepsy Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global First Generation AEDs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Second Generation AEDs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti Epilepsy Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Partial Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Generalized Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti Epilepsy Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti Epilepsy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti Epilepsy Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti Epilepsy Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti Epilepsy Drugs Market Competitive Analysis
-
14.1 UCB Pharma
-
14.1.1 UCB Pharma Company Details
-
14.1.2 UCB Pharma Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 UCB Pharma Anti Epilepsy Drugs Product and Service
-
14.2 Cephalon
-
14.2.1 Cephalon Company Details
-
14.2.2 Cephalon Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cephalon Anti Epilepsy Drugs Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Anti Epilepsy Drugs Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Anti Epilepsy Drugs Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Anti Epilepsy Drugs Product and Service
-
14.6 Sunovion Pharmaceuticals
-
14.6.1 Sunovion Pharmaceuticals Company Details
-
14.6.2 Sunovion Pharmaceuticals Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sunovion Pharmaceuticals Anti Epilepsy Drugs Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Anti Epilepsy Drugs Product and Service
-
14.8 Abbott Laboratories
-
14.8.1 Abbott Laboratories Company Details
-
14.8.2 Abbott Laboratories Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Abbott Laboratories Anti Epilepsy Drugs Product and Service
-
14.9 Johnson & Johnson
-
14.9.1 Johnson & Johnson Company Details
-
14.9.2 Johnson & Johnson Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Johnson & Johnson Anti Epilepsy Drugs Product and Service
-
14.10 Valeant Pharmaceuticals
-
14.10.1 Valeant Pharmaceuticals Company Details
-
14.10.2 Valeant Pharmaceuticals Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Valeant Pharmaceuticals Anti Epilepsy Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti Epilepsy Drugs
-
Figure Anti Epilepsy Drugs Picture
-
Table Global Anti Epilepsy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti Epilepsy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti Epilepsy Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti Epilepsy Drugs Consumption by Country (2017-2022)
-
Figure United States Anti Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Anti Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Anti Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Anti Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti Epilepsy Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Anti Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global First Generation AEDs Consumption and Growth Rate (2017-2022)
-
Figure Global Second Generation AEDs Consumption and Growth Rate (2017-2022)
-
Figure Global Partial Consumption and Growth Rate (2017-2022)
-
Figure Global Generalized Consumption and Growth Rate (2017-2022)
-
Figure Global First Generation AEDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Second Generation AEDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Partial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Generalized Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti Epilepsy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti Epilepsy Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table UCB Pharma (Foundation Year, Company Profile and etc.)
-
Table UCB Pharma Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Pharma Anti Epilepsy Drugs Product and Service
-
Table Cephalon (Foundation Year, Company Profile and etc.)
-
Table Cephalon Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cephalon Anti Epilepsy Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Anti Epilepsy Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Anti Epilepsy Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Anti Epilepsy Drugs Product and Service
-
Table Sunovion Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sunovion Pharmaceuticals Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunovion Pharmaceuticals Anti Epilepsy Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anti Epilepsy Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Anti Epilepsy Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Anti Epilepsy Drugs Product and Service
-
Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals Anti Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals Anti Epilepsy Drugs Product and Service
-
